Overview
What is Washington Institute For Coagulation?
The Washington Institute For Coagulation, also known as the Washington Center for Bleeding Disorders (WACBD), is a nonprofit organization based in Seattle, Washington. Their mission is to ensure optimal health for individuals with bleeding disorders by providing comprehensive care, education, and research in collaboration with patients, their families, and the local and national bleeding disorders community. As a recognized hemophilia treatment center and center of excellence, they offer clinical services across Washington state, neighboring states, and Alaska. Their multidisciplinary team of healthcare professionals addresses various concerns, including diagnosis, treatment, education, health insurance, orthopedics, dentistry, and more. They foster patient autonomy and cause minimal disruption to their lives. Expert pediatric services are coordinated with specialists at various hospitals, and outreach clinics are conducted in Tri-Cities, Yakima, Spokane, Wenatchee, and Olympia. Additionally, home visits, in-service meetings with healthcare professionals, and community resources for hemophilia care, emergency room treatment, invasive procedures, and other medical specialty clinics are provided throughout the state.
Official website here: www.wacbd.org
Is Washington Institute For Coagulation legitimate?
Washington Institute For Coagulation is a legitimate nonprofit organization registered as a 501(c)(3) entity. Washington Institute For Coagulation submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.
Here are some key statistics you may want to consider:
Executive Compensation: $296,091
Professional Fundraising Fees: $0
Other Salaries and Wages: $2,528,337
For more financial information, click here
Official website here: www.wacbd.org
What is the mission statement of Washington Institute For Coagulation?
The Washington Institute For Coagulation, also known as the Washington Center for Bleeding Disorders (WACBD), is committed to ensuring optimal health for individuals with bleeding disorders. Through comprehensive care, education, and research, WACBD collaborates with patients, their families, and the local and national bleeding disorders community. The organization's mission is to secure, promote, and protect the wellbeing of patients across the state and neighboring regions. The multidisciplinary team of healthcare professionals addresses various concerns, including diagnosis, treatment, education, insurance, orthopedics, dentistry, and emergency room treatment. Expert pediatric services are coordinated with specialists, and outreach clinics are conducted in multiple locations. Program staff facilitates community resources for hemophilia care and various medical specialty clinics.
Official website here: www.wacbd.org
Who is the CEO of Washington Institute For Coagulation?
Kim Snyder is the Executive/Medical Director of Washington Institute For Coagulation.
Official website here: www.wacbd.org
What is the revenue of Washington Institute For Coagulation?
Washington Institute For Coagulation's revenue in 2022 was $53,405,497.
Official website here: www.wacbd.org
Who are the executives of Washington Institute For Coagulation and what are their salaries?
- Rebecca Kruse-Jarres Md (Executive/Medical Director)
- Nicole Jobson (Operations Dir. & Privacy)
- Kristian Prill Hamilton (President) [Trustee/Director]
- Neil Josephson Md (Vice President) [Trustee/Director]
- Kathleen Verb Jd (Secretary) [Trustee/Director]
- Kim Snyder (Treasurer) [Trustee/Director]
- Krishna Jafa (Board Member) [Trustee/Director]
Official website here: www.wacbd.org
Where can I find the form 990 for Washington Institute For Coagulation?
The Washington Institute For Coagulation’s most recent form 990 was submitted in 2022 and can be accessed here
Official website here: www.wacbd.org
Learn more at the official website: www.wacbd.org
Mission Statement of Washington Institute For Coagulation
The Washington Institute For Coagulation, also known as the Washington Center for Bleeding Disorders (WACBD), is a dedicated organization that prioritizes the wellbeing of individuals with bleeding disorders. With a mission to secure, promote, and protect optimal health, the institute offers comprehensive care, education, and research in partnership with patients, their families, and the local and national bleeding disorders community.
WACBD's commitment extends beyond Washington state, as they cater to patients across neighboring states and Alaska. Their team of healthcare professionals addresses various concerns related to diagnosis, treatment, education, health insurance, orthopedics, dentistry, and more. Expert pediatric services are coordinated with specialists at renowned hospitals such as Seattle Children's Hospital and Providence Sacred Heart Medical Center.
WACBD's multidisciplinary approach ensures refined diagnosis and assessment, secure access to therapies, and comprehensive treatment planning. They foster their patients' autonomy, allowing them to safely care for their disorder and causing minimal disruption to their lives. The team provides home visits and in-service meetings with healthcare professionals throughout Washington state, while also coordinating community resources for hemophilia care, emergency room treatment, invasive procedures, and other medical specialty clinics. Furthermore, outreach clinics are conducted in Tri-Cities, Yakima, Spokane, Wenatchee, and Olympia.
Impact
This information is meant to be a general summary of Washington Institute For Coagulation. Please take the time to review official sources before making any decisions based upon the content provided here.
Thursday, August 15, 2024
The Washington Institute for Coagulation, through its Washington Center for Bleeding Disorders (WACBD), has a significant impact on the health and wellbeing of individuals with bleeding disorders. As a recognized hemophilia treatment center and a center of excellence, they are committed to providing comprehensive care, education, and research to patients in Washington, neighboring states, and Alaska.
Their multidisciplinary team of healthcare professionals works tirelessly to refine diagnosis and assessment, ensure secure access to therapies, and develop comprehensive treatment plans for patients. By fostering patient autonomy and minimizing disruptions to their lives, the institute empowers individuals to safely manage their bleeding disorders.
Additionally, the WACBD conducts outreach clinics, home visits, and in-service meetings to ensure that patients across the state of Washington have access to specialized care. They also coordinate community resources for emergency room treatments, invasive procedures, and other medical specialty clinics.
The impact of the Washington Institute for Coagulation extends beyond individual patient care to the broader bleeding disorders community. Through their dedication to research, education, and partnership with patients and their families, they play a vital role in securing, promoting, and protecting optimal health for those affected by bleeding disorders.
Financials
This financial information is from Propublica.
Other financial information:
This information is from the most recently submitted tax form from this organization, which was in 2022.
- Assets and Liabilities:
Programs
Programs are reported by nonprofits in their tax forms and are normally their tax-exempt activities.
PHARMACEUTICAL SALES
Revenue
$53,017,808
CLINICAL RESEARCH SERV
Revenue
$348,282
Organization Details
Founding Year
2018
Phone
(206) 614-1200
Principal Officer
Kim Snyder
Main Address
701 PIKE STREET 1900, SEATTLE, WA, 98101
Website
www.wacbd.org
NTEE Category
Code: G90 - Disease
If you are a representative of Washington Institute For Coagulation and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.